Emma works within the firm’s Life Sciences group, with a particular focus on pharmaceuticals. She has been involved in the prosecution of many European patent applications for the firm’s pharma clients and has a growing portfolio of cases directed to pharmaceutical products, medical uses and dosage regimes. Emma’s work spans all aspects of European patent prosecution, including the opposition of European patents post-grant. Outside of Europe, Emma has worked on patent applications from around the world and is involved in coordinating the prosecution of patent families in countries including the USA, Japan, China, South Korea, Canada, Singapore and India.
Emma has experience in the litigation of European patents within the UK and the rest of Europe. This includes the recent litigation of the European patent relating to Novartis’ Exelon® product, both in the UK High Court and other European jurisdictions. In parallel, Emma worked on the post-grant opposition of this same patent before the European Patent Office, which involved fourteen opponents. Emma has also worked closely with the firm’s Dispute Resolution team on several recent UK litigation cases.
Emma joined Carpmaels & Ransford in 2010 after completing a Master’s degree in Chemistry at the University of Oxford and qualified as both a UK Patent Attorney and European Patent Attorney in 2014.
In her spare time, Emma enjoys spending time with her family and attempting to improve her baking skills.
- MChem (University of Oxford)
- Chartered Patent Attorney
- European Patent Attorney
- Intellectual Property Litigation Certificate